Key Figures
| All figures are given in millions of € according to IFRS, unless otherwise specified | 2019 | 2018 | 2017 | 2016 | 2015 |
| Order intake, sales revenue and earnings | |||||
| Order intake | 1,543.5 | 1,307.3 | 1,162.3 | 1,080.8 | 946.4 |
| Sales revenue | 1,440.6 | 1,212.2 | 1,081.0 | 1,051.6 | 884.3 |
| Underlying EBITDA1, 2) | 421.5 | 342.4 | 294.9 | 288.7 | 231.3 |
| Underlying EBITDA1, 2) as % of sales revenue | 29.3 | 28.2 | 27.3 | 27.5 | 26.2 |
| Net profit after non-controlling interest | 234.6 | 208.1 | 161.1 | 153.7 | 118.0 |
| Underlying net profit1) after non-controlling interest2) | 262.9 | 219.3 | 180.4 | 176.6 | 139.3 |
| Research and development costs | 79.2 | 60.6 | 53.2 | 47.5 | 41.5 |
| Financial data per share3) | |||||
| Earnings per share | 2.54 | 2.26 | 1.75 | 1.67 | 1.28 |
| Earnings per share (in €)1, 4) | 2.85 | 2.38 | 1.96 | 1.92 | 1.51 |
| Dividend per share (in €) | 0.685) | 0.57 | 0.46 | 0.42 | 0.33 |
| Balance sheet | |||||
| Balance sheet total | 1,820.4 | 1,571.5 | 1,403.9 | 1,195.8 | 1,066.1 |
| Equity | 1,177.6 | 1,044.9 | 879.5 | 763.6 | 647.2 |
| Equity ratio (in %) | 64.7 | 66.5 | 62.6 | 63.9 | 60.7 |
| Financials | |||||
| Capital expenditures6) | 136.0 | 177.0 | 136.7 | 80.2 | 54.5 |
| Capital expenditures as % of sales revenue6) | 9.4 | 14.6 | 12.6 | 7.6 | 6.2 |
| Depreciation and amortization | 73.2 | 60.9 | 50.6 | 44.7 | 39.4 |
| Cash flow from operating activities | 310.1 | 227.3 | 174.7 | 156.7 | 142.8 |
| Net debt7) | 107.7 | 125.7 | 127.1 | 67.6 | 86.4 |
| Ratio of net debt to underlying EBITDA1, 2) | 0.3 | 0.4 | 0.4 | 0.2 | 0.4 |
| Total number of employees as of December 31 | 6,203 | 5,637 | 5,092 | 4,725 | 4,202 |
1) Adjusted for extraordinary items
2) For more information on EBITDA, net profit and the underlying presentation, please refer to the Group Business Development chapter and to the Glossary.
3) 2015 adjusted for stock split; rounded values
4) Adjusted for extraordinary items, non-cash amortization acc. to IFRS 3 and fair value adjustments of hedging instruments, as well as the corresponding tax effects for each of these items.
5) Amount suggested by the Board of Directors (Conseil d’administration) and subject to approval by the Annual General Shareholders’ Meeting.
6) Since 2019 and as a result of the change in IFRS 16 accounting principles, CAPEX has been based on cash flow instead of balance sheet computation; CAPEX restated for 2018: €176.5 million; CAPEX ratio restated for 2018: 14.6% for FY 2018
7) Net debt excludes the liability for the remaining purchase price for acquisitions; 2019: 72.5 million euros, 2018: 8.7 million euros, 2017: 46.5 million euros, 2016: 49.6 million euros, 2015: 47.5 million euros